Rockwell Medical, Inc. (Nasdaq: RMTI) has closed the previously announced $15 Million in financing, consisting of $12 Million in a Registered Direct Offering, and $3 Million in a private investment in public equity (PIPE), both priced at-market, with Armistice Master Fund Ltd. The closing occurred on June 2, 2022.

In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States.

Rockwell Medical Closes $15 Million Financing From Leading Healthcare Investor

Description

Company Information

Funding Insights

Rockwell Medical Closes $15 Million Financing From Leading Healthcare Investor

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information